Yao Wang Minan Zhang Qingfeng Xue Huan Zhou Jie Chen Hong Wang Yaping Zhang Wenyu Shi
10.3389/fimmu.2023.1172307
Front Immunol
2023 Apr 17;14:1172307.
pd-1 inhibitor chronic active epstein-barr virus disease extranodal nk/t-cell lymphoma hemophagocytic lymphohistiocytosis single-cell transcriptomics
CC BY
https://pubmed.ncbi.nlm.nih.gov/37138889/
Epstein-Barr Virus Infections / complications Epstein-Barr Virus Infections / drug therapy Lymphoma, Extranodal NK-T-Cell / diagnosis Lymphoma, Extranodal NK-T-Cell / drug therapy Lymphoma, Extranodal NK-T-Cell / pathology Lymphoproliferative Disorders / diagnosis
Epstein-Barr Virus Infections / complications Epstein-Barr Virus Infections / drug therapy Lymphoma, Extranodal NK-T-Cell / diagnosis Lymphoma, Extranodal NK-T-Cell / drug therapy Lymphoma, Extranodal NK-T-Cell / pathology Lymphoproliferative Disorders / diagnosis Case Reports Research Support, Non-U.S. Gov't Herpesvirus 4, Human Humans Immune Checkpoint Inhibitors / therapeutic use Transcriptome Immune Checkpoint Inhibitors
PMC10149821
37138889
Case report: Immune modulation after PD-1 inhibitor therapy in a patient with extranodal NK/T-cell lymphoma secondary to chronic active Epstein-Barr virus disease unveiled by single-cell transcriptomics
2023